Baillie Gifford & Co
TRHC

Baillie Gifford & Co’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Baillie Gifford & Co’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-831,278
Closed -$6.86M – 300
2023
Q2 		$6.86M Hold
831,278
– – 0.01% 232
2023
Q1 		$4.65M Sell
831,278
-415
-0% -$2.38K ﹤0.01% 243
2022
Q4 		$4.12M Hold
831,693
– – ﹤0.01% 249
2022
Q3 		$3.99M Buy
831,693
+1,419
+0.2% +$6.08K ﹤0.01% 246
2022
Q2 		$2.13M Sell
830,274
-1,416
-0.2% -$5.31K ﹤0.01% 262
2022
Q1 		$4.79M Sell
831,690
-249,807
-23% -$2.24M ﹤0.01% 253
2021
Q4 		$16.2M Buy
1,081,497
+31,998
+3% +$583K 0.01% 227
2021
Q3 		$27.5M Sell
1,049,499
-7,218
-0.7% -$266K 0.01% 211
2021
Q2 		$52.8M Buy
1,056,717
+44,490
+4% +$1.99M 0.03% 190
2021
Q1 		$46.6M Buy
1,012,227
+273,434
+37% +$13M 0.03% 190
2020
Q4 		$31.6M Buy
738,793
+73,642
+11% +$2.8M 0.02% 182
2020
Q3 		$27.1M Buy
665,151
+207,888
+45% +$10.4M 0.02% 170
2020
Q2 		$25M Buy
+457,263
New +$26.2M 0.02% 166

Other funds holding TRHC

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BSCM
Berry Street Capital Management London, United Kingdom $340M AUM 65.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Baillie Gifford & Co's TRHC Position: Q3 2023 in Review

Baillie Gifford & Co sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q3 2023, closing a stake of 831,278 shares — an estimated $6.86M sold.

Baillie Gifford & Co first reported a position in TRHC in Q2 2020 and held it in 13 quarters. The position peaked at $52.8M in Q2 2021. 84 funds tracked by Wall St. Rank hold TRHC as of Q3 2023.

  • Baillie Gifford & Co reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 831,278 Tabula Rasa HealthCare, Inc. Common Stock shares in Q3 2023, an estimated $6.86M.
  • Baillie Gifford & Co first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2020 and held it in 13 quarters.
  • Baillie Gifford & Co's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $52.8M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q3 2023.

Based on Baillie Gifford & Co's 13F filing for Q3 2023, filed 13 Nov 2023.